Is Colinz Laboratories Ltd debt-free?

Yes, Colinz Laboratories Ltd is debt-free with a debt-to-equity ratio of 0.07.

Home

Colinz Laboratories Ltd

Colinz Laboratories Ltd Financials

Colinz Laboratories Ltd Financial Statement

Colinz Laboratories Ltd Income Statement

Quarterly

Annual

*All values are in Rs. Cr

Particulars	Jun 2025	Mar 2025	Dec 2024
Revenue	1.64	1.53	1.54
Operating Expense	1.43	1.35	1.40
Net Profit	0.12	0.15	0.05
Net Profit Margin	7.32	9.80	3.25
Earning Per Share	0.47	0.60	0.21
EBIDTA	0.21	0.17	0.14
Effective Tax Rate	19.05	-17.65	35.71

Particulars	Jun 2025
Revenue	1.64
Operating Expense	1.43
Net Profit	0.12
Net Profit Margin	7.32
Earning Per Share	0.47
EBIDTA	0.21
Effective Tax Rate	19.05

Colinz Laboratories Ltd Profit & Loss

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2025	Mar 2024	Mar 2023
Total Revenue Annual	6.53	7.03	7.15
Operating Expenses Annual	6.03	6.49	6.55
Operating Profit Annual	0.79	0.82	0.78
Interest Annual	0.04	0.04	0.05
Depreciation	0.13	0.13	0.13
Net Profit Annual	0.50	0.49	0.46
Tax Annual	0.12	0.16	0.14

Particulars	Mar 2025
Total Revenue Annual	6.53
Operating Expenses Annual	6.03
Operating Profit Annual	0.79
Interest Annual	0.04
Depreciation	0.13
Net Profit Annual	0.50
Tax Annual	0.12

Colinz Laboratories Ltd Cash Flow

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2025	Mar 2024	Mar 2023
Cash Flow at the Beginning	7	5.73	5.21
Cash Flow from Operations	-1.45	1.03	0.40
Cash Flow from Investing	-0.23	0.01	0.01
Cash Flow from Financing	0.24	0.23	0.11
Cash Flow at the End	5.55	7	5.73

Particulars	Mar 2025
Cash Flow at the Beginning	7
Cash Flow from Operations	-1.45
Cash Flow from Investing	-0.23
Cash Flow from Financing	0.24
Cash Flow at the End	5.55

Colinz Laboratories Ltd Key Ratios

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2025	Mar 2024	Mar 2023
PBDIT Margin (%)	12.10	11.66	10.91
PBIT Margin (%)	10.11	9.82	9.09
PBT Margin (%)	-242.57	-235.56	-172.73
Net PROFIT Margin (%)	7.66	6.97	6.43
Return On Networth / Equity (%)	5.43	5.73	5.81
Return On Networth /Employed (%)	6.72	7.70	7.82
Return On Assets (%)	5.13	5.44	5.53
Total Debt / Equity (X)	0.07	0.05	0.05
Asset Turnover Ratio (%)	0.67	0.78	0.86

Particulars	Mar 2025
PBDIT Margin (%)	12.10
PBIT Margin (%)	10.11
PBT Margin (%)	-242.57
Net PROFIT Margin (%)	7.66
Return On Networth / Equity (%)	5.43
Return On Networth /Employed (%)	6.72
Return On Assets (%)	5.13
Total Debt / Equity (X)	0.07
Asset Turnover Ratio (%)	0.67

Colinz Laboratories Ltd Balance Sheet

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2025	Mar 2024	Mar 2023
Fixed Assets Annual	1.70	1.58	1.71
Total Current Assets Annual	9.02	8.74	7.84
Non Current Assets Annual	2.80	2.62	2.40
Total Shareholders Funds Annual	9.47	8.95	8.14
Total Assets Annual	11.82	11.36	10.23

Particulars	Mar 2025
Fixed Assets Annual	1.70
Total Current Assets Annual	9.02
Non Current Assets Annual	2.80
Total Shareholders Funds Annual	9.47
Total Assets Annual	11.82

Colinz Laboratories Ltd Earning Calls

No Data Availabe

Dividend Pages

PE Ratio

FAQS on Colinz Laboratories Ltd Financials

As of Sep 4, 2025, Colinz Laboratories Ltd has a market capitalization of 33.11 Cr. Value Research classifies it as a Micro-Cap company.

Yes, Colinz Laboratories Ltd is with a debt-to-equity ratio of 0.07.

In FY 2024 , Colinz Laboratories Ltd recorded a total revenue of approximately 6.53 Cr marking a significant milestone in the company's financial performance.

Colinz Laboratories Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately 0.4% and -0.0% annually, respectively..

Colinz Laboratories Ltd's current PE ratio is 66.22.

Colinz Laboratories Ltd's ROCE averaged 7.2% from the FY ending March 2023 to 2025, with a median of 7.2%. It peaked at 7.8% in March 2023, reflecting strong capital efficiency over the period..

Colinz Laboratories Ltd's latest EBIT is Rs. 0.66 Cr, surpassing the average EBIT of Rs. 0.67 Cr over the 5 years..